Gregory J. Riely on the Identification and Treatment of MET Exon 14 Skipping Mutations

Gregory J. Riely, associate attending physician, Memorial Sloan Kettering Cancer Center, discusses identifying and treating patients with MET exon 14 skipping mutations in lung cancer.

Gregory J. Riely, associate attending physician, Memorial Sloan Kettering Cancer Center, discusses identifying and treating patients with MET exon 14 skipping mutations in lung cancer.

Related Content:

CURE TVLung Cancer
Support for Patients Undergoing Treatment for NSCLC
How to Decide on Novel Therapy for EGFR Exon 20–Positive NSCLC
Educating Patients About Cancer Should Not Be a ‘One-Size-Fits-All’ Approach, Says Expert